Management of babies born to mothers who are on prescribed or misuse medications (opiate and related) leading to drug withdrawal features (Management of Neonatal Abstinence Syndrome (NAS)
Neonatal
October 12, 2021
This guideline is currently under review and remains in place during the review process
This guideline will be going to the December Neonatal Clinical Oversight Group for Ratification
This is the NAS Guideline and Benchmark for the East of England Neonatal ODN